These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34062154)

  • 21. In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3.
    Huang S; Zhou D; Li YX; Ming ZY; Li KZ; Wu GB; Chen C; Zhao YN
    J Cell Physiol; 2019 Apr; 234(4):3500-3514. PubMed ID: 30370582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic downregulation of the suppressor of cytokine signaling 1 (Socs1) gene is associated with the STAT3 activation and development of hepatocellular carcinoma induced by methyl-deficiency in rats.
    Bagnyukova TV; Tryndyak VP; Muskhelishvili L; Ross SA; Beland FA; Pogribny IP
    Cell Cycle; 2008 Oct; 7(20):3202-10. PubMed ID: 18843197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma.
    Zhou Q; Zhang W; Wang Z; Liu S
    BMC Cancer; 2019 Jul; 19(1):731. PubMed ID: 31340767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-137 suppresses migration and invasion by targeting EZH2-STAT3 signaling in human hepatocellular carcinoma.
    Huang B; Huang M; Li Q
    Pathol Res Pract; 2018 Dec; 214(12):1980-1986. PubMed ID: 30274685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
    Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
    Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression.
    Yan S; Tang Z; Chen K; Liu Y; Yu G; Chen Q; Dang H; Chen F; Ling J; Zhu L; Huang A; Tang H
    J Exp Clin Cancer Res; 2018 Sep; 37(1):214. PubMed ID: 30176933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma.
    Subramaniam A; Shanmugam MK; Perumal E; Li F; Nachiyappan A; Dai X; Swamy SN; Ahn KS; Kumar AP; Tan BK; Hui KM; Sethi G
    Biochim Biophys Acta; 2013 Jan; 1835(1):46-60. PubMed ID: 23103770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Roles and Regulation of Long Noncoding RNAs in Hepatocellular Carcinoma.
    Lim LJ; Wong SYS; Huang F; Lim S; Chong SS; Ooi LL; Kon OL; Lee CG
    Cancer Res; 2019 Oct; 79(20):5131-5139. PubMed ID: 31337653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-coding RNAs in hepatocellular carcinoma metastasis: Remarkable indicators and potential oncogenic mechanism.
    Qiu W; Zhang S; Yu W; Liu J; Wu H
    Comput Biol Med; 2024 Sep; 180():108867. PubMed ID: 39089114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decoding the Roles of Long Noncoding RNAs in Hepatocellular Carcinoma.
    Wong LS; Wong CM
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The HNF1α-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1.
    Ding CH; Yin C; Chen SJ; Wen LZ; Ding K; Lei SJ; Liu JP; Wang J; Chen KX; Jiang HL; Zhang X; Luo C; Xie WF
    Mol Cancer; 2018 Feb; 17(1):63. PubMed ID: 29466992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of H19/miR-326 axis in hepatocellular carcinoma development through modulating TWIST1.
    Wei LQ; Li L; Lu C; Liu J; Chen Y; Wu H
    J Cell Physiol; 2019 Apr; 234(4):5153-5162. PubMed ID: 30362512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maintenance of stemness by miR-589-5p in hepatocellular carcinoma cells promotes chemoresistance via STAT3 signaling.
    Long J; Jiang C; Liu B; Dai Q; Hua R; Chen C; Zhang B; Li H
    Cancer Lett; 2018 Jun; 423():113-126. PubMed ID: 29196128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development.
    Zhang N; Chen X
    Cell Oncol (Dordr); 2020 Feb; 43(1):137-153. PubMed ID: 31691159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1.
    Wang YG; Wang T; Shi M; Zhai B
    J Exp Clin Cancer Res; 2019 Apr; 38(1):153. PubMed ID: 30971290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The long non-coding RNA, SNHG6-003, functions as a competing endogenous RNA to promote the progression of hepatocellular carcinoma.
    Cao C; Zhang T; Zhang D; Xie L; Zou X; Lei L; Wu D; Liu L
    Oncogene; 2017 Feb; 36(8):1112-1122. PubMed ID: 27530352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non‑coding RNAs in HBV‑related hepatocellular carcinoma (Review).
    Zhang H; Chen X; Zhang J; Wang X; Chen H; Liu L; Liu S
    Int J Oncol; 2020 Jan; 56(1):18-32. PubMed ID: 31746420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of LncRNA ANRIL Potential in Hepatic Cancer Progression.
    Ji Y; Sun H; Liang H; Wang Y; Lu M; Guo Z; Lv Z; Ren W
    J Environ Pathol Toxicol Oncol; 2019; 38(2):119-131. PubMed ID: 31679275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The long noncoding RNA
    Ren Y; Shang J; Li J; Liu W; Zhang Z; Yuan J; Yang M
    J Biol Chem; 2017 Oct; 292(43):17939-17949. PubMed ID: 28887306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA DCST1-AS1 functions as a competing endogenous RNA to regulate FAIM2 expression by sponging miR-1254 in hepatocellular carcinoma.
    Chen J; Wu D; Zhang Y; Yang Y; Duan Y; An Y
    Clin Sci (Lond); 2019 Jan; 133(2):367-379. PubMed ID: 30617187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.